Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Intervalo de año de publicación
1.
Am J Physiol Renal Physiol ; 292(3): F921-9, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17132866

RESUMEN

Previously, we showed that neonatal induced chronic partial unilateral ureteral obstruction (PUUO) of the multipapillary pig kidney decreased glomerular filtration rate (GFR) of the obstructed kidney. We hypothesized that ANG II and nitric oxide (NO) are important for the changes in renal function and in the present study we examined the effects of chronic AT1 receptor blockade using CV-11974 (0.12 mg/h candesartan from age 23 to 30 days) on kidney function development after PUUO was induced in 2-day-old piglets. Moreover, the effect of superimposed acute NO inhibition using N(G)-nitro-l-arginine methyl ester (l-NAME; 15 mg/kg) was examined to identify if this has diagnostic potential. PUUO significantly increased GFR in the nonobstructed contralateral kidney independent of candesartan. In candesartan-treated piglets, the l-NAME-induced GFR reduction seen in normal and nonobstructed kidneys was absent in the partial obstructed kidneys. Urine output and fractional excretion of water were increased from the partial obstructed kidneys. Consistent with this immunohistochemical analyses showed a reduced aquaporin-2 labeling in the collecting duct principal cells. Moreover, renal sodium handling was compromised by PUUO evidenced by an increased fractional excretion of sodium which was enhanced by candesartan treatment. In conclusion, our findings suggest that the counterbalance between AT1 receptor-mediated vasoconstriction and NO-mediated vasodilatation which maintain GFR in normal young porcine kidneys is changed by neonatal induced chronic PUUO. This may have diagnostic potential in children with suspected congenital obstruction. Our results also demonstrate compromised tubular functions in response to chronic PUUO despite preservation of glomerular function.


Asunto(s)
Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacología , Glomérulos Renales/fisiopatología , Túbulos Renales/fisiopatología , Riñón/fisiopatología , Obstrucción Ureteral/fisiopatología , Animales , Animales Recién Nacidos , Acuaporina 2/metabolismo , Bencimidazoles/farmacología , Compuestos de Bifenilo , Inhibidores Enzimáticos/farmacología , Femenino , Tasa de Filtración Glomerular/efectos de los fármacos , Transporte Iónico/efectos de los fármacos , Riñón/efectos de los fármacos , Riñón/crecimiento & desarrollo , Corteza Renal/efectos de los fármacos , Corteza Renal/metabolismo , Corteza Renal/patología , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/metabolismo , Médula Renal/efectos de los fármacos , Médula Renal/metabolismo , Médula Renal/patología , Túbulos Renales/efectos de los fármacos , Túbulos Renales/metabolismo , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , ATPasas de Translocación de Protón/metabolismo , Sodio/metabolismo , Sus scrofa , Tetrazoles/farmacología , Obstrucción Ureteral/metabolismo , Agua/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA